PDE5 pathway support compounds work differently for different men because the upstream signal they amplify — eNOS-derived nitric oxide — is genetically variable. NOS3 genotype sets the vascular floor. The Precision Peptide Genetic Test maps this and other pathway variables across 14 pathways, 49 peptides, and 150+ genetic insights, explaining the response variability that dosing alone cannot.

Yes — eNOS genetics directly shapes the nitric oxide foundation that vascular sexual response is built on. NOS3 variants determine how much NO your endothelium produces per arousal signal. The Precision Peptide Genetic Test analyzes eNOS variants as part of 14 pathways, 49 peptides, and 150+ genetic insights, answering the question bloodwork alone cannot.

Erectile function depends on multiple gene-governed systems — nitric oxide production, central arousal signaling, dopamine-driven desire, and cGMP preservation. The Precision Peptide Genetic Test maps the key variants across 14 pathways, 49 peptides, and 150+ genetic insights, identifying the genetic architecture that testosterone panels and vascular tests alone cannot reveal.

The vasoactive pathway governs genital blood flow through multiple parallel mechanisms — nitric oxide, prostaglandin signaling, and alpha-adrenergic tone — each with its own genetic variable. The Precision Peptide Genetic Test maps key vasoactive pathway variants as part of 14 pathways, 49 peptides, and 150+ genetic insights, revealing the full vascular architecture that sexual arousal depends on.

PDE5 pathway support works differently for different people — and genetics is one of the most direct explanations for that variability. The Precision Peptide Genetic Test maps upstream NOS3 and downstream pathway variables as part of 14 pathways, 49 peptides, and 150+ genetic insights, explaining the vascular dimension of differential response.

eNOS — the endothelial nitric oxide synthase enzyme encoded by NOS3 — is the genetic starting point of the vascular cascade that sexual arousal depends on. The Precision Peptide Genetic Test analyzes NOS3 variants as part of 14 pathways, 49 peptides, and 150+ genetic insights, mapping the upstream NO signal before it reaches the PDE5 pathway.

The Precision Peptide Genetic Test analyzes 6 Sexual Health insights covering the four systems behind sexual response — vascular (eNOS, PDE5), dopamine (DRD2), bonding (OXTR), and circadian (MTNR1B) — within 14 pathways, 49 peptides, and 150+ genetic insights. This pillar breaks down what each gene reveals and why sexual health is a multi-system problem.

The Precision Peptide Genetic Test analyzes your genetic response to the pathways targeted by 49 unique compounds across five protocol families — GLP-1, growth hormone, androgens, estrogens, and vascular modulators. This post breaks down how each protocol family maps to genetic pathways, what the 49-peptide panel covers, and what your results reveal.

Genetic testing reveals tendencies, not outcomes — a FOXO3 variant doesn't predict lifespan, a slow-COMT variant doesn't diagnose any condition, an ACTN3 XX genotype doesn't cap muscle growth. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150+ genetic insights. Understanding what DNA can and cannot tell you is the difference between informed and overconfident.

Before committing to a peptide protocol, genetic testing reveals how your body will actually respond across GLP-1 signaling, growth hormone axis, estrogen clearance, and sexual response pathways. The Precision Peptide Genetic Test maps 14 pathways, 49 peptides, and 150+ genetic insights. Test first. Invest second. That sequence is the entire premise of precision peptide decisions.